secwatch.observer — SEC 8-K summary
======================================

Issuer:     Bone Biologics Corp (BBLG)
CIK:        0001419554
Form:       8-K
Filed at:   2024-10-21T23:59:59+00:00
Accession:  0001493152-24-041710
Event type: leadership
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Bone Biologics appoints Phillip Meikle to board, replacing retiring director Don Hankey
--------------------------------------------------------------------------------

- Phillip Meikle appointed to Bone Biologics board effective October 16, 2024.
- Meikle founded Biosystems of New England (sold to Stryker in 2019), 30+ years orthopedic/spine experience.
- Don R. Hankey retired from board after seven years of service; board size stays at four.
- Meikle will be compensated in the same manner as other Bone Biologics directors.
- No arrangements or transactions requiring disclosure under Item 404(a) were identified.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1419554/000149315224041710/0001493152-24-041710-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1419554/000149315224041710/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-041710

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer